IS7971A - Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða - Google Patents

Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða

Info

Publication number
IS7971A
IS7971A IS7971A IS7971A IS7971A IS 7971 A IS7971 A IS 7971A IS 7971 A IS7971 A IS 7971A IS 7971 A IS7971 A IS 7971A IS 7971 A IS7971 A IS 7971A
Authority
IS
Iceland
Prior art keywords
erythema
cave
diffuse
peptide
pharmaceutical preparation
Prior art date
Application number
IS7971A
Other languages
English (en)
Inventor
Cohen-Vered Sharon
Naftali Esmira
Weinstein Vera
Gilbert Adrian
Klinger Ety
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/000955 external-priority patent/WO2004064788A2/en
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of IS7971A publication Critical patent/IS7971A/is

Links

IS7971A 2004-01-14 2005-08-05 Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða IS7971A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/000955 WO2004064788A2 (en) 2003-01-14 2004-01-14 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

Publications (1)

Publication Number Publication Date
IS7971A true IS7971A (is) 2005-08-05

Family

ID=36701521

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7971A IS7971A (is) 2004-01-14 2005-08-05 Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða

Country Status (1)

Country Link
IS (1) IS7971A (is)

Similar Documents

Publication Publication Date Title
IS7972A (is) Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða
NO20073482L (no) Fremgangsmåte til å stabilisere antidement medikament
NO2019033I1 (no) regorafenib
DK2727583T3 (da) Lægemiddelbærer og lægemiddelbærerkit til at inhibere fibrose
IL181779A (en) A group of protein-based medical molecules
ATE419769T2 (de) System mit kapsel mit dichtmitteln
DK2609947T3 (da) Plasterlignende infusionsapparat
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
EP1784219A4 (en) STABILIZING FORMULATIONS
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
DK2471807T3 (da) Langtids-virkende polypeptider og fremgangsmåder til produktion og administration af samme
DE602004017700D1 (de) Transmukosen verabreichung
DE602005026235D1 (de) Kapsel-endoskop
ATE425952T1 (de) (biphenyl)carbonsauren und derivate davon
NO20053119D0 (no) Farmasoytiske sarmmensetninger med fentanyl for intranasal administrasjon.
EA200500101A1 (ru) Лекарственное средство для коррекции патологических иммунных реакций
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
ATE546141T1 (de) Pharmazeutisches injektionspräparat
ATE397618T1 (de) Peptidcyclisierung
DK1809660T3 (da) Thymus-specifikt protein
DE112006001343A5 (de) Patientenauflage
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
IS7971A (is) Lyfjagerð með peptíði til meðhöndlunar utan meltingarvegar á dreifðum helluroða
PL1753412T3 (pl) Samorozgrzewający plaster farmaceutyczny
EP1767635A4 (en) FLUORESCENT PROTEIN